Literature DB >> 25357110

American Joint Committee on Cancer Staging and clinicopathological high-risk predictors of ocular surface squamous neoplasia: a study from a tertiary eye center in India.

Sheetal Chauhan1, Seema Sen, Anjana Sharma, Radhika Tandon, Seema Kashyap, Neelam Pushker, Murugesan Vanathi, Namrata Sharma.   

Abstract

CONTEXT: Ocular surface squamous neoplasia (OSSN) is the most common tumor of conjunctival epithelium associated with risk of permanent visual impairment. It includes conjunctival intraepithelial neoplasia and squamous cell carcinoma. Although American Joint Committee on Cancer-TNM (AJCC-TNM) staging is commonly used in various tumors, it has only recently been described for OSSN.
OBJECTIVES: To evaluate the prognostic relevance of AJCC-TNM staging and the clinicopathological features in OSSN.
DESIGN: Sixty-four histopathologically proven cases of OSSN (20 conjunctival intraepithelial neoplasia and 44 squamous cell carcinoma) were included in the study. The AJCC-TNM staging and clinicopathological features of OSSN cases were recorded. Patients were followed up for 17 to 40 months (median, 32 months). Univariate and multivariate analyses were performed to determine the prognostic value of various clinicopathological features.
RESULTS: Longer sunlight exposure (P = .01), diffuse growth pattern (P = .02), larger tumor size (≥2 cm) (P = .03), histopathological diagnosis of squamous cell carcinoma (P = .02), and orbital invasion or invasion of adjacent structures (T3 or T4) (P < .001) emerged as significant predictors of reduced recurrence-free survival. Using multivariate analysis, a higher T category (T3 or T4) was the most important prognostic indicator of a poor outcome.
CONCLUSIONS: A higher T category (T3 or T4) is an important predictor of clinical outcome, and the use of the AJCC-TNM staging system is recommended in the management of all patients with OSSN. Longer sunlight exposure, larger tumor size (≥2 cm), orbital invasion or invasion of adjacent structures (T3 or T4), and a histopathological diagnosis of squamous cell carcinoma are other clinicopathological features of prognostic relevance in patients with OSSN.

Entities:  

Mesh:

Year:  2014        PMID: 25357110     DOI: 10.5858/arpa.2013-0353-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

1.  Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia.

Authors:  Ashley Polski; Maria Sibug Saber; Jonathan W Kim; Jesse L Berry
Journal:  Clin Exp Ophthalmol       Date:  2018-11-13       Impact factor: 4.207

2.  Characteristics, management, and outcome of squamous carcinoma of the conjunctiva in a single tertiary cancer center in Jordan.

Authors:  Ata Rajeh; Fareed Barakat; Samer Khurma; Khaleel AlRawashdeh; Osama H Ababneh; Ibrahim AlNawaiseh; Mustafa Mehyar; Ghadeer Abdeen; Imad Jaradat; Mona Mohammad; Yacoub A Yousef
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779

3.  Conjunctival Squamous Neoplasia: Staging and Initial Treatment.

Authors:  Claudine Bellerive; Jesse L Berry; Ashley Polski; Arun D Singh
Journal:  Cornea       Date:  2018-10       Impact factor: 2.651

4.  The role of ultrasonography in differential diagnosis of orbital lesions.

Authors:  Vittoria Lanni; Adriana Iuliano; Federica Fossataro; Camilla Russo; Giovanni Uccello; Fausto Tranfa; Diego Strianese; Gianfranco Vallone
Journal:  J Ultrasound       Date:  2020-03-12

5.  A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom.

Authors:  Christine A Kiire; Rosalind M K Stewart; Sathish Srinivasan; Heinrich Heimann; Stephen B Kaye; Baljean Dhillon
Journal:  Eye (Lond)       Date:  2018-12-28       Impact factor: 3.775

6.  Differential Expression of Stem Cell Markers in Ocular Surface Squamous Neoplasia.

Authors:  Dilip Kumar Mishra; Uppala Veena; Swathi Kaliki; Abhinav Reddy Kethiri; Virender S Sangwan; Mohammed Hasnat Ali; Milind N Naik; Vivek Singh
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

7.  Clinicodemographic profile and treatment outcome in patients of ocular surface squamous neoplasia.

Authors:  Rachna Meel; Rebika Dhiman; Murugesan Vanathi; Neelam Pushker; Radhika Tandon; Saranya Devi
Journal:  Indian J Ophthalmol       Date:  2017-10       Impact factor: 1.848

8.  PD-L1/PD1 Expression, Composition of Tumor-Associated Immune Infiltrate, and HPV Status in Conjunctival Squamous Cell Carcinoma.

Authors:  Priyadharsini Nagarajan; Christian El-Hadad; Stephen K Gruschkus; Jing Ning; Courtney W Hudgens; Oded Sagiv; Neil Gross; Michael T Tetzlaff; Bita Esmaeli
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-05-01       Impact factor: 4.799

9.  Prognostic Factors for Orbital Exenteration, Local Recurrence, Metastasis, and Death From Disease in Conjunctival Squamous Cell Carcinoma.

Authors:  Christian El-Hadad; Maria Laura Rubin; Priya Nagarajan; Joshua Richard Ford; Shiqiong Xu; Jing Ning; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2021 May-Jun 01       Impact factor: 2.011

Review 10.  Clinical Management of Ocular Surface Squamous Neoplasia: A Review of the Current Evidence.

Authors:  Maria Vittoria Cicinelli; Alessandro Marchese; Francesco Bandello; Giulio Modorati
Journal:  Ophthalmol Ther       Date:  2018-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.